Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Tokuda

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2002
[Trastuzumab (Herceptin)]Yutaka Tokuda, Yasuhiro Suzuki, Yuuki Saitou, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 15, 2012
A comparative clinical evaluation of the assay of serum extracellular domain of HER2 protein using a chemiluminescent immunoassay method in breast cancer patients with or without HER2 protein expression in immunohistochemistrySeiichi Mokuyasu, Yasuhiro Suzuki, Takayuki Seto, et al.
Breast Cancer (Tokyo, Japan)|November 30, 2011
Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004-2009Shigehira Saji, Masahiro Hiraoka, Yutaka Tokuda, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Breast cancer]Yutaka Tokuda, Yuki Saito, Yasuhiro Suzuki, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 9, 2005
Clinicopathological correlation between expression of PTHrP receptor and various prognostic factors in breast cancer without axillary lymph node metastasisYasuhiro Suzuki, Yutaka Tokuda, Yuki Saito, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2006
Two cases of ductal adenoma of the breastKen-ichi Okada, Yasuhiro Suzuki, Yuki Saito, et al.
Breast Cancer (Tokyo, Japan)|February 4, 2011
Alteration of immunohistochemical biomarkers between pre- and post-chemotherapy: hormone receptors, HER2 and Ki-67Nobue Kumaki, Shinobu Umemura, Xiaoyan Tang, et al.
Japanese Journal of Clinical Oncology|February 26, 2008
Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapyYasuhiro Suzuki, Yutaka Tokuda, Yasuhiro Fujiwara, et al.
Breast Cancer (Tokyo, Japan)|July 14, 2011
Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II studyShintaro Takao, Yutaka Tokuda, Toshiaki Saeki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 14, 2011
Assessment of dyspnea in terminally ill cancer patients: role of the thoracic surgeon as a palliative care physicianKazuho Yoshino, Noboru Nishiumi, Ryota Masuda, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2002
[Trastuzumab (Herceptin)]Yutaka Tokuda, Yasuhiro Suzuki, Yuuki Saitou, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 15, 2012
A comparative clinical evaluation of the assay of serum extracellular domain of HER2 protein using a chemiluminescent immunoassay method in breast cancer patients with or without HER2 protein expression in immunohistochemistrySeiichi Mokuyasu, Yasuhiro Suzuki, Takayuki Seto, et al.
Breast Cancer (Tokyo, Japan)|November 30, 2011
Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004-2009Shigehira Saji, Masahiro Hiraoka, Yutaka Tokuda, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2002
[Breast cancer]Yutaka Tokuda, Yuki Saito, Yasuhiro Suzuki, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 9, 2005
Clinicopathological correlation between expression of PTHrP receptor and various prognostic factors in breast cancer without axillary lymph node metastasisYasuhiro Suzuki, Yutaka Tokuda, Yuki Saito, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2006
Two cases of ductal adenoma of the breastKen-ichi Okada, Yasuhiro Suzuki, Yuki Saito, et al.
Breast Cancer (Tokyo, Japan)|February 4, 2011
Alteration of immunohistochemical biomarkers between pre- and post-chemotherapy: hormone receptors, HER2 and Ki-67Nobue Kumaki, Shinobu Umemura, Xiaoyan Tang, et al.
Japanese Journal of Clinical Oncology|February 26, 2008
Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapyYasuhiro Suzuki, Yutaka Tokuda, Yasuhiro Fujiwara, et al.
Breast Cancer (Tokyo, Japan)|July 14, 2011
Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II studyShintaro Takao, Yutaka Tokuda, Toshiaki Saeki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 14, 2011
Assessment of dyspnea in terminally ill cancer patients: role of the thoracic surgeon as a palliative care physicianKazuho Yoshino, Noboru Nishiumi, Ryota Masuda, et al.
Pageof 13